DE19510861A1 - Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen - Google Patents

Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen

Info

Publication number
DE19510861A1
DE19510861A1 DE19510861A DE19510861A DE19510861A1 DE 19510861 A1 DE19510861 A1 DE 19510861A1 DE 19510861 A DE19510861 A DE 19510861A DE 19510861 A DE19510861 A DE 19510861A DE 19510861 A1 DE19510861 A1 DE 19510861A1
Authority
DE
Germany
Prior art keywords
estradiol
month
peri
replacement therapy
hormone replacement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19510861A
Other languages
German (de)
English (en)
Inventor
Ursula Dr Dr Lachnit-Fixson
Semiramis Aydinlik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19510861A priority Critical patent/DE19510861A1/de
Priority to PCT/EP1996/001201 priority patent/WO1996028165A1/de
Priority to ARP960101766A priority patent/AR002283A1/es
Priority to JP8527295A priority patent/JPH11501649A/ja
Priority to AU51108/96A priority patent/AU713258B2/en
Priority to CZ972896A priority patent/CZ289697A3/cs
Priority to MX9707009A priority patent/MX9707009A/es
Priority to PL96322202A priority patent/PL322202A1/xx
Priority to CA002215382A priority patent/CA2215382A1/en
Priority to EP96907506A priority patent/EP0814811A1/de
Priority to SK1239-97A priority patent/SK123997A3/sk
Priority to NZ304027A priority patent/NZ304027A/xx
Priority to HU9801691A priority patent/HUP9801691A3/hu
Priority to KR1019970706467A priority patent/KR19980703058A/ko
Priority to IL11751696A priority patent/IL117516A/xx
Priority to ZA962177A priority patent/ZA962177B/xx
Publication of DE19510861A1 publication Critical patent/DE19510861A1/de
Priority to NO974255A priority patent/NO974255L/no
Priority to US09/348,232 priority patent/US20010006963A1/en
Priority to US10/062,569 priority patent/US20020193358A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE19510861A 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen Withdrawn DE19510861A1 (de)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
EP96907506A EP0814811A1 (de) 1995-03-16 1996-03-15 Einmonatsspritze als depot-kontrazeptivum und für die hormonersatztherapie für peri- und praemenopausale frauen
SK1239-97A SK123997A3 (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women
JP8527295A JPH11501649A (ja) 1995-03-16 1996-03-15 閉経周辺期及び閉経前期にある女性に対する徐放性避妊薬としての及びホルモン補充療法に使用する１月用注射薬
AU51108/96A AU713258B2 (en) 1995-03-16 1996-03-15 Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
CZ972896A CZ289697A3 (en) 1995-03-16 1996-03-15 Injection administered once a month as a depot contraception and for hormonal substitution therapy for women in perimenstrual and premenstrual pause
MX9707009A MX9707009A (es) 1995-03-16 1996-03-15 Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.
PL96322202A PL322202A1 (en) 1995-03-16 1996-03-15 Monthly injections as a contraceptive measure for and in substitute hormonal therapy of pre- and in-menopausal female patients
CA002215382A CA2215382A1 (en) 1995-03-16 1996-03-15 Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
PCT/EP1996/001201 WO1996028165A1 (de) 1995-03-16 1996-03-15 Einmonatsspritze als depot-kontrazeptivum und für die hormonersatztherapie für peri- und praemenopausale frauen
ARP960101766A AR002283A1 (es) 1995-03-16 1996-03-15 Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.
NZ304027A NZ304027A (en) 1995-03-16 1996-03-15 Once a month injectable contraceptive comprising an estrogenic and gestagenic component for contraception and simultaneous hormone replacement therapy
HU9801691A HUP9801691A3 (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women
KR1019970706467A KR19980703058A (ko) 1995-03-16 1996-03-15 폐경기 중 및 폐경기 전 여성을 위한 호르몬 대체 치료 및데포 피임제로서 유용한 월 1회 주사제
IL11751696A IL117516A (en) 1995-03-16 1996-03-17 Injectable composition containing an oestrogenic component and a gestagenic component
ZA962177A ZA962177B (en) 1995-03-16 1996-03-18 Once-a-month injectable composition as a depot contraceptive and for hormone replacement therapy for peri- and pre-menopausal women
NO974255A NO974255L (no) 1995-03-16 1997-09-15 Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner
US09/348,232 US20010006963A1 (en) 1995-03-16 1999-07-06 Once-a-month injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
US10/062,569 US20020193358A1 (en) 1995-03-16 2002-02-05 Once-a-month injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen

Publications (1)

Publication Number Publication Date
DE19510861A1 true DE19510861A1 (de) 1996-09-19

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19510861A Withdrawn DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen

Country Status (17)

Country Link
EP (1) EP0814811A1 (sk)
JP (1) JPH11501649A (sk)
KR (1) KR19980703058A (sk)
AR (1) AR002283A1 (sk)
AU (1) AU713258B2 (sk)
CA (1) CA2215382A1 (sk)
CZ (1) CZ289697A3 (sk)
DE (1) DE19510861A1 (sk)
HU (1) HUP9801691A3 (sk)
IL (1) IL117516A (sk)
MX (1) MX9707009A (sk)
NO (1) NO974255L (sk)
NZ (1) NZ304027A (sk)
PL (1) PL322202A1 (sk)
SK (1) SK123997A3 (sk)
WO (1) WO1996028165A1 (sk)
ZA (1) ZA962177B (sk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
NO974255D0 (no) 1997-09-15
NZ304027A (en) 2000-05-26
NO974255L (no) 1997-11-14
IL117516A (en) 2000-07-26
MX9707009A (es) 1997-11-29
IL117516A0 (en) 1996-07-23
CZ289697A3 (en) 1997-12-17
PL322202A1 (en) 1998-01-19
HUP9801691A3 (en) 1999-03-01
ZA962177B (en) 1996-07-29
KR19980703058A (ko) 1998-09-05
AR002283A1 (es) 1998-03-11
AU5110896A (en) 1996-10-02
JPH11501649A (ja) 1999-02-09
WO1996028165A1 (de) 1996-09-19
CA2215382A1 (en) 1996-09-19
EP0814811A1 (de) 1998-01-07
AU713258B2 (en) 1999-11-25
SK123997A3 (en) 1998-02-04
HUP9801691A2 (hu) 1998-11-30

Similar Documents

Publication Publication Date Title
DE3916112C2 (sk)
DE69003015T4 (de) Behandlung von Störungen in der Postmenopause.
EP0499348B1 (de) Ovulationshemmendes Mittel zur hormonalen Kontrazeption
EP0735881B1 (de) Mittel und verfahren zur hormonalen kontrazeption und/oder zur aknebehandlung
DE69118494T2 (de) Kontrazeptionsverfahren und Schema
EP0735883B1 (de) Zusammensetzung für die empfängnisverhütung umfassend ein estrogen und ein gestagen
DE69532894T2 (de) Verfahren zur empfängnisverhütung
DE69804918T2 (de) Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung
EP0770388B1 (de) Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
EP0148724B1 (de) Mehrstufenkombinationspräparat und seine Verwendung zur oralen Kontrazeption
EP0628312B1 (de) Kombinationspräparat zur Kontrazeption
EP0835114B1 (de) Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption
EP0750501B1 (de) Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption
EP1310257A2 (de) Kombination zur hormonalen Kontrazeption
DE69729956T2 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
DE69327319T2 (de) Minimierung von mit progesteron verbundenen durchbruckblutungen
DE4330234A1 (de) Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE69721314T2 (de) Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält
WO1994002103A2 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
DE19513662A1 (de) Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE602004009288T2 (de) Verwendung einer kombination eines aromatasehemmers, eines progestins und eines oestrogens zur behandlung von endometriose
DE3787386T2 (de) In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung.
DE69827017T2 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DE19510861A1 (de) Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
DE4405591C1 (de) Mittel zur postmenopausalen Hormonsubstitution

Legal Events

Date Code Title Description
8141 Disposal/no request for examination
8110 Request for examination paragraph 44
8170 Reinstatement of the former position
8130 Withdrawal